ライフサイエンスコーパス: plasmid DNA

1 d ssDNA and stabilize negative supercoils in plasmid DNA.

2 immune responses following immunization with plasmid DNA.

3 key phosphorylation site involved in DNA-PK) plasmid DNA.

4 a novel eukaryotic alternative to bacterial plasmid DNA.

5 mited by detection of contaminating viral or plasmid DNA.

6 rocapsule position on cell transfection with plasmid DNA.

7 plexes formed using BFDMA and macromolecular plasmid DNA.

8 crA helicase to bind and begin unwinding the plasmid DNA.

9 ed muscles over muscles treated with "naked" plasmid DNA.

10 nse than intramuscular injection of the same plasmid DNA.

11 and DNA nodes, within negatively supercoiled plasmid DNA.

12 in vivo and in human genomic DNA spiked with plasmid DNA.

13 iates at multiple single-stranded regions of plasmid DNA.

14 DNA preparations are contaminated with XMRV plasmid DNA.

15 cles (VLPs) when expressed individually from plasmid DNA.

16 tion of 12 novel DeltaG rabies variants from plasmid DNA.

17 actions participate in the immunogenicity of plasmid DNA.

18 oduction of a single negative supercoil into plasmid DNA.

19 he promoter region of the human BCL2 gene in plasmid DNA.

20 ed only in HEK293 cells transfected with the plasmid DNA.

21 e local microbubble-enhanced sonoporation of plasmid DNA.

22 n health, often residing in extrachromosomal plasmid DNA.

23 ved 20% 5-gmC in the genome and 45% 5-gmC in plasmid DNA.

24 wer for the attenuated DNA and close for the plasmid DNA.

25 asmid DNA and per 10(8) cells with a 13.8 kb plasmid DNA.

26 m minicircles was 5-10-fold higher than with plasmid DNA.

27 st defense by interfering with the uptake of plasmid DNA.

28 (HFFs) infected with HSV or transfected with plasmid DNA.

29 and influencing intracellular trafficking of plasmid DNA.

30 264.7 and DC 2.4 cells using GFP-expressing plasmid DNA.

31 omplexes with a high packaging efficiency of plasmid DNA.

32 idge between PEGylated anionic liposomes and plasmid DNA.

33 These studies were done with plasmid DNA (~2.6 kilobase (kb)) in JM109 E. coli cells.

34 issue, we used intradermal immunization with plasmid DNA, a system in which activation of CD8(+) T ce

35 ticles or by intramuscular immunization with plasmid DNA alone.

36 und that mice injected with 50mug luciferase plasmid DNA and 5x10(5) microbubbles followed by ultraso

37 Using plasmid DNA and a homologous duplex oligonucleotide with

38 as detected, but only in animals primed with plasmid DNA and boosted with trimeric protein.

39 caused restriction of incoming bacteriophage/plasmid DNA and endogenous chromosomal DNA within Escher

40 cationic polymers and fluorescently labeled plasmid DNA and injected them intradermally into mice.

41 to consistently enhance the delivery of both plasmid DNA and messenger RNA payloads in stem cells, pr

42 formation efficiency up to 10(7) CFU per mug plasmid DNA and per 10(8) cells with a 13.8 kb plasmid D

43 1(+) rhesus monkeys through vaccination with plasmid DNA and recombinant adenovirus encoding simian-h

44 onfocal live cell imaging, we show that both plasmid DNA and siRNA are internalised via endocytosis.

45 ipathic histidine rich peptides possess high plasmid DNA and siRNA delivery capabilities.

46 homatis mouse pneumonitis (MoPn) genomic and plasmid DNA and tested it with serum samples from MoPn-i

47 Heterologous prime-boost immunization with plasmid DNA and viral vector vaccines is an emerging app

48 M-LMNs loaded with plasmid DNA and/or doxorubicin are efficiently taken up

49 h viral genomes, binds to incoming viral and plasmid DNAs and deposits histone H3.3 onto these.

50 ong double-stranded DNAs, including circular plasmid DNAs and genomic DNAs.

51 , were susceptible to the virus rescued from plasmid DNAs and supported production of the virus over

52 es were evaluated using combinations of both plasmid-DNA and transposase-protein relocalization to th

53 ase of various drugs including mitoxantrone, plasmid DNA, and a chemokine from the scaffold.

54 s, germline transgenesis, electroporation of plasmid DNA, and microinjection of morpholinos are all r

55 es not affect the biological activity of the plasmid DNA, and that the core-shell formulations have n

56 is not required for efficient replication of plasmid DNA, and they suggest that DNA functions as a co

57 Possible roles for Sub1 proteins in NHEJ of plasmid DNA are discussed.

58 of redox control observed for lipoplexes of plasmid DNA are maintained in complexes formed using sma

59 including small interfering RNA (siRNA) and plasmid DNA, are important tools for the study of mammal

60 Here, we describe the use of plasmid DNA as a stable, robust and configurable scaffol

61 Monofunctional pyriplatin reacted with plasmid DNA as efficiently as bifunctional cisplatin and

62 now prime DNA synthesis using the recipient plasmid DNA as template, circumventing a lesion that blo

63 , we tested a different formulation in which plasmid DNA associates with the surface of preformed 20-

64 human and canine cells partition transfected plasmid DNA asymmetrically, preferentially into the daug

65 lasmid release from the complex and so limit plasmid DNA availability.

66 necessary to orchestrate the propagation of plasmid DNA between bacterial cells through conjugative

67 with spiky surfaces demonstrate the highest plasmid DNA binding capability and transfection efficacy

68 , BALB/c mice were given three injections of plasmid DNA-Bla g 1 prior to sensitization with two prim

69 y enhanced bone regeneration compared to PEI-plasmid DNA (BMP-2)-activated matrices.

70 SUB1 is required for NHEJ repair of DSBs in plasmid DNA, but not in chromosomal DNA.

71 h cisplatin enhances double-strand breaks of plasmid DNA by a factor of approximately 3.5 and dramati

72 rt that (-)-lomaiviticin A nicks and cleaves plasmid DNA by a pathway that is independent of reactive

73 nwinding of both linear and natural circular plasmid DNA by PcrA/RepD was followed in real-time using

74 delivery via simultaneous administration of plasmid DNA by the i.m. and i.d. routes.

75 he type IV REase in restricting 5mC-modified plasmid DNA by transformation into clinical S. aureus st

76 Sufficient plasmid DNA can be isolated from 100 ml E. coli cultures

77 The uncut plasmid DNA can be used for transfection if the sole pur

78 le-mediated transcutaneous immunization with plasmid DNA can potentially induce a stronger immune res

79 e screening, rolling circle amplification of plasmid DNA, capillary electrophoresis and automated dig

80 eractive transposase, together with circular plasmid DNA carrying a transgene construct flanked by bi

81 SB100X hyperactive transposase together with plasmid DNA carrying a transgene construct flanked by bi

82 Stable transfection of HEK-293T cells with plasmid DNA carrying EqCXCL16 (HEK-EqCXCL16 cells) incre

83 with saline, injected with uncompacted naked plasmid DNA carrying the Rds gene, or remained untreated

84 measurements of a model system of clustered plasmid-DNA centered by the dynamically unstable actin-l

85 Mini plasmid DNA circles with three or five operators positio

86 licited a stronger immune response than with plasmid DNA-coated net negatively charged nanoparticles

87 Transcutaneous immunization with plasmid DNA-coated net positively charged nanoparticles

88 Transcutaneous immunization with plasmid DNA-coated net positively charged nanoparticles

89 rticles are composed of a single molecule of plasmid DNA compacted with block copolymers of poly-L-ly

90 noparticles, composed of single molecules of plasmid DNA compacted with block copolymers of poly-l-ly

91 linked to itself interacts differently with plasmid DNA compared to conventional vectors and when te

92 hese data demonstrate that mucosally applied plasmid DNA complexed to PEI followed by a mucosal prote

93 Significant differences in behavior toward plasmid DNA condensation are correlated with biological

94 MS11 was enhanced by the addition of excess plasmid DNA containing a DUS while FA1090 transformation

95 ional non-viral gene transfer uses bacterial plasmid DNA containing antibiotic resistance genes, cis-

96 say using mammalian cell nuclear extract and plasmid DNA containing bulky adducts formed by N-acetoxy

97 as they require embryos to be injected with plasmid DNA containing the exon tag.

98 thin the procapsid and recircularizes linear plasmid DNA containing two terminal loxP recognition sit

99 g poly beta-amino ester (PBAE) polymers with plasmid DNAs containing a GFP reporter gene.

100 was shown to be required for replication of plasmid DNAs containing covalent DNA-protein complexes.

101 cted nucleosome positioning in vitro on four plasmid DNAs containing DNA fragments derived from the g

102 Cells mixed with plasmid DNA continuously flowed through a serpentine cha

103 ceptor-targeted, DNA-binding peptide (P) and plasmid DNA (D), which electrostatically self-assembled

104 We monitored plasmid DNA degradation using gel electrophoresis and qP

105 -27 protein produced upon hydrodynamic IL-27 plasmid DNA delivery when combined with IL-2.

106 MCF-7 and A549 cells and compared this with plasmid DNA delivery.

107 iption-coupled hypernegative supercoiling of plasmid DNA did not need the expression of a membrane-in

108 o centrosomes together bias the partition of plasmid DNA during mitosis.

109 Importantly, use of plasmid DNA enabled lower depth sequencing, and assembli

110 strate co-delivery of luciferase protein and plasmid DNA encoding a fluorescent protein from two diff

111 We utilized two kinds of plasmid DNA encoding either BMP-2 or FGF-2 formulated in

112 ing a natural phenomenon observed in tumors, plasmid DNA encoding for a soluble ligand to NKG2D (sRAE

113 Here, we show that vaccination with plasmid DNA encoding H1N1 influenza hemagglutinin (HA) a

114 , we administered intracranial injections of plasmid DNA encoding IL-10 (pDNA-IL-10) into the NAc of

115 e prepared via freeze drying and loaded with plasmid DNA encoding perlecan domain I and VEGF189 and a

116 The plasmid DNA encoding perlecan domain I and VEGF189 loade

117 umor immunity induced upon immunization with plasmid DNA encoding SV40 Tag as a transgene (pCMV-Tag).

118 Lung delivery of plasmid DNA encoding the CFTR gene complexed with a cati

119 By sequentially immunizing mice with plasmid DNA encoding the hemagglutinin of antigenically

120 we inoculated nonhuman primates (NHPs) with plasmid DNA encoding transmembrane-anchored, cleaved JRF

121 s suggest that chitosan scaffolds containing plasmid DNA encoding VEGF189 and perlecan domain I have

122 Optimized plasmid DNAs encoding the majority of SIVmac239 proteins

123 Two groups were primed with plasmid DNAs encoding the secreted form of glycoprotein

124 arisons with PEI complexed with conventional plasmid DNA (encoding BMP-2).

125 UvrC from Mtb collectively bound and cleaved plasmid DNA exposed to ultraviolet (UV) irradiation or p

126 d hydrodynamic injection to deliver a CRISPR plasmid DNA expressing Cas9 and single guide RNAs (sgRNA

127 uine IgG obtained from horses immunized with plasmid DNA followed by boosting with Kunjin replicon vi

128 ecifically evaluated the advantages of using plasmid DNA for sequencing and the value of supplementin

129 can be genetically programmed with nonviral plasmid DNA for the biogenesis and delivery of antisense

130 ation of parasites in a sample, we developed plasmid DNAs for all the three assay targets for absolut

131 We show that peptide efficiently packaged plasmid DNA forming spherical, highly cationic nanocompl

132 We show that the pulmonary delivery of plasmid DNA formulated with polyethyleneimine (PEI-DNA)

133 i, such as by insertion of foreign (viral or plasmid) DNA fragments into clustered regularly interspa

134 NA method was employed for the extraction of plasmid DNA from bacterial cell lysate.

135 ve B. burgdorferi much more efficiently than plasmid DNA from E. coli, particularly when the bbe02 an

136 donii-cAM373, does indeed induce transfer of plasmid DNA from E. faecalis into S. gordonii.

137 rBCP was also found to protect supercoiled plasmid DNA from oxidative damage (i.e., nicking) in vit

138 or CMV, or transient transfection with naked plasmid DNA, HIRA re-localizes to PML bodies, sites of c

139 sp and Imu1-3 and examined their activity on plasmid DNA, human umbilical vein endothelial cells, and

140 distinct types of T cell immunity, improves plasmid DNA immunization, including mobilization of CD8(

141 , spontaneous brain tumors were induced with plasmid DNA in a matter of weeks in three separate mouse

142 persistent transgene expression compared to plasmid DNA in a number of organ systems but has not bee

143 cytic choriomeningitis virus infection using plasmid DNA in a prime, but not prime-boost, vaccination

144 study demonstrates for the first time use of plasmid DNA in absolute quantification of malaria parasi

145 Polyphenols extracted from honeys degraded plasmid DNA in the presence of H2O2 and Cu(II) in the Fe

146 on of HPV-11, -16, and -18 origin-containing plasmid DNA in transfected cells at concentrations well

147 n this study we compared minicircle DNA with plasmid DNA in transfections of airway epithelial cells.

148 transfection of luciferase and GFP reporter plasmid DNA in vitro and in vivo under various condition

149 urination mediated by cruciform formation in plasmid DNA in vitro.

150 reconstituted pre-RCs support replication of plasmid DNA in yeast cell extracts in a reaction that ex

151 Our results elucidate the evolution of plasmid DNAs in red algae and suggest that they spread a

152 mbinase (ZFR) fusion proteins that integrate plasmid DNA into a synthetic target site in the human ge

153 ng protein that targets chromosomes, carries plasmid DNA into cells, and shows specificity for active

154 ow efficient delivery of biologically active plasmid DNA into CHO-K1 cells.

155 First, they transport plasmid DNA into Escherichia coli about 2-fold over cont

156 used to directly catalyze the integration of plasmid DNA into mammalian genomes, there is still an un

157 The cationic Man-CS-Phe micelles condense plasmid DNA into nanoscale polyplexes and provide effici

158 This material effectively condenses plasmid DNA into salt-stable particles that deshield und

159 ped two polymeric gene carriers that compact plasmid DNA into small and highly stable nanoparticles w

160 optimized protocol for biolistic delivery of plasmid DNA into the epidermis of Arabidopsis leaves, wh

161 IFI16 also restricted the expression of plasmid DNAs introduced by transfection but did not rest

162 wever, whether the immunogenic properties of plasmid DNA involve TLR9 signaling has not been clearly

163 n-induced single-strand-break (SSB) yield in plasmid DNA involves measurement of the fraction of rela

164 Although plasmid DNA is a promising tool bearing the unique poten

165 When the input is on, plasmid DNA is degraded 10(8)-fold.

166 Circular carrier plasmid DNA is included during subsequent DNA purificati

167 Conjugation, the process by which plasmid DNA is transferred from one bacterium to another

168 orbent surface leads to full recovery of all plasmid DNA isoforms, which is a major issue when using

169 d, with the best-performing model applied to plasmid DNA isolated from Escherichia coli and mitochond

170 is co-transfected with transposon-containing plasmid DNA, it penetrates prokaryotic or eukaryotic cel

171 improves microparticle-based transfection of plasmid DNA lipoplexes in several primary human cell typ

172 antly enhanced survival compared to the same plasmid DNA loaded in DNA-CN in two aggressive orthotopi

173 se in the expression of a reporter gene when plasmid DNA-loaded particles were used.

174 uciferase reporter gene) to form a liposomal-plasmid DNA (LpDNA) complex.

175 Plasmid DNA may exist in three isoforms, the linear, ope

176 e prophylactic and therapeutic efficacy of a plasmid DNA-mediated vaccination using the Bla g 1 gene

177 ptide with a nucleic acid binding domain and plasmid-DNA, minicircle-DNA or small interfering RNA (si

178 To maximize cytokine production from plasmid DNA, molecular steps controlling IL-12p70 biosyn

179 Each plasmid DNA molecule encodes many origins of synthesis.

180 ata demonstrated that the mean SSB yield per plasmid DNA molecule of [21.2+/-0.59]x10(-2)Gy(-1) as me

181 oscopy confirmed that mouse PPy/u containing-plasmid DNA molecules under the different structural str

182 Plasmid DNA molecules with unique loop structures have w

183 -DNA nanoparticles are capable of delivering plasmid DNA of different size into cells in culture, yie

184 imultaneous delivery of siRNA and linearized plasmid DNA on the surface of a single nanocrystal provi

185 s were significantly enhanced by coating the plasmid DNA on the surface of cationic nanoparticles.

186 d by transcutaneous immunization by applying plasmid DNA onto a skin area pretreated with solid micro

187 that transcutaneous immunization by applying plasmid DNA onto a skin area wherein the hair follicles

188 idazoles do not cause nicking of supercoiled plasmid DNA or cleavage of bovine serum albumin.

189 ys, the transfected cell microarray, wherein plasmid DNA or siRNA, spotted on the surface of a substr

190 o this include making use of vectors such as plasmid DNA or viruses, live attenuated pathogens or sub

191 ved ORF analyses showed that the majority of plasmid DNAs originated within red algae, whereas others

192 ession in recipient cells resulted only from plasmid DNA (pDNA) after delivery via MVs.

193 Commutability of plasmid DNA (pDNA) and genomic DNA (gDNA) calibrators fo

194 dermal administration of nucleic acids, both plasmid DNA (pDNA) and siRNA, to treat localised disease

195 ic polyamine disulfides to condense and cage plasmid DNA (pDNA) by a process of thermodynamically con

196 on of macrophages transfected ex vivo with a plasmid DNA (pDNA) encoding a potent antioxidant enzyme,

197 Oral administration of the plasmid DNA (pDNA) encoding GLP-1 decreased diabetic glu

198 The developed plasmid DNA (pDNA) individually produced both IAPP and L

199 Import of exogenous plasmid DNA (pDNA) into mammalian cell nuclei represents

200 ers were characterized for size, morphology, plasmid DNA (pDNA) loading and surface charge.

201 Electroporation (EP) for plasmid DNA (pDNA) vaccine delivery has demonstrated the

202 HIV-derived conserved element (CE) p24(gag) plasmid DNA (pDNA) vaccine is able to redirect immunodom

203 ase or angiotensin II type 2 receptor (AT2R) plasmid DNA (pDNA) was evaluated in Lewis lung carcinoma

204 dle delivery of nucleic acids, in particular plasmid DNA (pDNA), to the skin represents a potential n

205 in which the liposomes are designed to carry plasmid DNA (pDNA, containing luciferase reporter gene)

206 hosphate (TMP), calf thymus DNA (CTDNA), and plasmid DNA (PLDNA) analyses.

207 subcutaneous injection of cationized gelatin/plasmid DNA polyplex into the rat hindpaw and its subseq

208 ame and quantity similar to those of routine plasmid DNA preparation, making it feasible to use minic

209 We detected adenine methylation of plasmid DNA prepared from B. burgdorferi that carried bb

210 Here we immunized rhesus monkeys by plasmid DNA prime and recombinant vaccinia virus boost w

211 e the transfection efficiency of GFP-encoded plasmid DNA (pRmHa3-GFP) into cells through efficient DN

212 A 300 bp plasmid DNA product was amplified within the disk and an

213 Nanomaterials in the form of plasmid DNA, proteins, and virus particles accumulate in

214 Finally, DNA-BPN loaded with anti-cancer plasmid DNA provided significantly enhanced survival com

215 However, plasmid DNA purified from B. burgdorferi transformed nai

216 l groups were primed with the empty backbone plasmid DNA (pVAX).

217 Indeed, we show that CN enhances plasmid DNA relaxation due to Fenton's reaction in vitro

218 s more potent than deglycoBLM in supercoiled plasmid DNA relaxation, while the analogue having the di

219 imilar are not equivalent and that repair of plasmid DNA requires additional factor(s) that are not r

220 Competition with plasmid DNA revealed that transformation of MS11 was enh

221 Plasmid DNA sequencing of previously uncharacterized cli

222 ry system can be extended to the delivery of plasmid DNA, siRNA, or aptamers for preclinical and clin

223 1 muL droplet of whole blood, and we amplify plasmid DNA spiked into whole blood droplets to represen

224 Furthermore, the efficient amplification of plasmid DNA spiked into whole blood proves that the larg

225 The use of plasmid DNA standard in quantification of malaria parasi

226 A recent publication showed that circular plasmid DNA standards grossly overestimated numbers of a

227 ed LDL-cholesterol oxidation and supercoiled plasmid DNA strand breakage inhibition induced by both p

228 nstitution of the VSP repair pathway using a plasmid DNA substrate.

229 as both MeC and C nucleobases in transfected plasmid DNA substrates are highly susceptible to editing

230 ) by combining traits reported to facilitate plasmid DNA synthesis (i.e., decreased Pyk flux and incr

231 transform plants by transferring a region of plasmid DNA, T-DNA, into host plant cells.

232 , and resulted in sequence homology with the plasmid DNA target.

233 The Sso-IIID complex can cleave plasmid DNA targets in vitro, generating linear DNA prod

234 n the successful construction of a series of plasmid DNA templates that contain many tandem copies of

235 y AraC and LacI can induce a Delta Lk to the plasmid DNA templates.

236 a procedure for the isolation of total rumen plasmid DNA, termed rumen plasmidome, and subjected it t

237 Here we describe an iDNA vaccine composed of plasmid DNA that encode the full-length infectious genom

238 orms stable complexes at both ends of linear plasmid DNA that protect the DSBs from digestion by 5'-

239 teria and archaea from invasion by phage and plasmid DNA through a genetic interference pathway.

240 demonstrated superior condensing ability for plasmid DNA through the formation of compact nanosized p

241 al and liposomal vectors for the delivery of plasmid DNA to cells for gene therapy applications.

242 mycobacteria, and to prevent segregation of plasmid DNA to daughter cells.

243 nanocarrier is found to effectively condense plasmid DNA to form a highly stable GNR-DSPEI-PEG-RGD/DN

244 e present study, we evaluated the ability of plasmid DNA to induce local and systemic antigen-specifi

245 ionalized fluorescent probes, antibodies, or plasmid DNA to living cells requires overcoming the plas

246 (DAB) dendrimer would allow the transport of plasmid DNA to the brain after intravenous administratio

247 imine dendrimer would allow the transport of plasmid DNA to the brain after intravenous administratio

248 eplicative relaxase and directly targets the plasmid DNA to the ICEBs1 conjugation apparatus.

249 The delivery of plasmid DNA to the skin can target distinct subsets of d

250 f PEI can be effective delivery vehicles for plasmid DNAs to elicit cellular and humoral protective r

251 a strategy to study platinum cross-links on plasmid DNAs transfected into live mammalian cells based

252 ut, contributing to a 2.5~3 fold increase on plasmid DNA transfection and an additional 10-55% transg

253 initiation factor eIF-2alpha seen following plasmid DNA transfection were both greatly reduced in AD

254 Using HIV-lentivector and plasmid DNA transfection, we also developed A2A and A2B

255 s for gene therapy of airway disorders where plasmid DNA transfections have so far proven inefficient

256 tact and attachment of the cells followed by plasmid DNA transfer prior to detachment.

257 One requires NHEJ of linearized plasmid DNA transformed into the test organism; the othe

258 Unlike T4CPs involved in plasmid DNA translocation, DotL appeared to function by

259 The segregation of plasmid DNA typically requires three elements: a DNA cen

260 ase of the bacterium (OD 6.0) using 25 ng of plasmid DNA under 100 Ohms resistance and 1.7 kV/cm volt

261 ounds exhibited significant photocleavage of plasmid DNA upon visible light irradiation and are rapid

262 ) and microRNA-125b-2 (miR-125b2) expressing plasmid DNA using hyaluronic acid-poly(ethylene imine)/h

263 1 chemokine MCP-1 during the early phases of plasmid DNA vaccination because injecting the type II NK

264 Finally, pulmonary, but not i.m., plasmid DNA vaccination protected mice from a lethal rec

265 ecause cytotoxic T-cell responses induced by plasmid DNA vaccination were reduced in Sting-deficient

266 activation, during the first days following plasmid DNA vaccination, NKT cells release IL-5 and MCP-

267 The 6-plasmid DNA vaccine (expressing clade B Gag, Pol, and Ne

268 A plasmid DNA vaccine and a single-shot recombinant rhesus

269 an influenza challenge model we show that a plasmid DNA vaccine complexed to a less toxic form of PE

270 vatives of PEI could be utilised for topical plasmid DNA vaccine delivery to human mucosal tissue sur

271 The magnitude and durability of a plasmid DNA vaccine-induced immune response is shaped by

272 emonstrates a critical role for NKT cells in plasmid DNA vaccine-induced immune responses.

273 IV-1 CN54gp140 antigen when cation-complexed plasmid DNA vaccines are applied topically to the murine

274 Plasmid DNA vaccines encoding the fusion genes generated

275 el methods for enhancing immune responses to plasmid DNA vaccines.

276 A plasmid DNA vector coding for the Bla g 1 allergen contr

277 te nanotopography of silica nanoparticles as plasmid DNA vectors has significant impact on the transf

278 , a new method of introducing mutations into plasmid DNA via a light-mediated mutagenesis protocol wa

279 Efficient in vitro electrotransfection of plasmid DNA was demonstrated in several hard-to-transfec

280 One copy of plasmid DNA was established to be equivalent to 0.1 para

281 Detection of HPV type-specific plasmid DNA was highly specific, with high signal-to-noi

282 The gel assay, which used supercoiled plasmid DNA, was sensitive to both SSBs and DSBs.

283 led to a luciferase bioluminescence reporter plasmid DNA were shown to transfect tumors implanted in

284 and the mobilities of circular versus linear plasmid DNAs were also affected by the chemical form and

285 are incorporated into cells or organisms as plasmid DNA, which leads the transcriptional and transla

286 sition of horizontally transferred phage and plasmid DNA, which provides virulence and resistance fun

287 an be derived from biologically synthesized (plasmid) DNA, which reduces errors associated with chemi

288 rR links the filaments with centromeric parC plasmid DNA, while facilitating the addition of subunits

289 (TopA67) but not full-TopA in the absence of plasmid DNA, while PrS-YjhX binds to full-TopA in the pr

290 orphologies are prepared via condensation of plasmid DNA with a block copolymer of polyethylene glyco

291 videnced by up to 16% recovery of the spiked plasmid DNA with a pore size of 0.2 mum.

292 rform multiple displacement amplification of plasmid DNA with a very low error rate.

293 ting stem-loop was confirmed by digestion of plasmid DNA with apurinic endonuclease IV, followed by p

294 Tth111II cleaves a two-site plasmid DNA with equal efficiency regardless of site ori

295 , and large fragments (>3000 bp) of digested plasmid DNA with good efficacy.

296 Treatment of plasmid DNA with H2O2 alone did not affect the DNA integ

297 nd simple system for delivering oncolytic Ad plasmid DNA with the bioreducible polymers, skipping tim

298 developed a novel system using oncolytic Ad plasmid DNA with two bioreducible polymers: arginine-gra

299 and extends the serum half-life of siRNA and plasmid DNA with which it is complexed.

300 null AdnAB is a helicase that unwinds linear plasmid DNA without degrading the displaced single stran